Shirley Wen
Founder/CEO
● 10+ years of interdisciplinary product and managing experience, transforming traditional businesses with frontier digital technologies
● Ex hegdefund portfolio manager, focused on healthcare, TMT, and consumer
● MSc Accounting & Finance, The London School of Economics
Douglas McCloskey, Ph.D.
Co-founder/Chief Scientist
● Systems biologist experienced in developing automated Big Omics Data generation and analysis workflows
● Group leader, Center for Biosustainability (CfB) at the Technical University of Denmark (DTU)
● Ph.D., Bioengineering, University of California, San Diego in the Bernhard Ø. Palsson lab
● Recipient of the Siebel Scholar – awarded annually for academic excellence and demonstrated leadership to 93 top students from the world‘s leading graduate schools
● Publication H-index of 21
Dimitris Christodoulou, Ph.D.
Co-founder/Chief Strategy Officer
● Strategist & computational biologist with experience in data analytics, multi-omics integration & simulation
● Ex-Senior Consultant at Deloitte Consulting (Zurich), led the design and implementation of business and technology strategies as well as data solutions for global MNCs
● Visiting Scholar in Systems Biology, Harvard Medical School
● Ph.D. & Post-Doc, Computational Biology, ETH Zurich
● Published multiple top tier publications (i.e. Nature, Cell Systems, iScience)
Xiaoqiang Hou, Ph.D.
Co-founder/Chief Operating Officer
● Deputy Secretary-General of Internet Hospital Association
● 20 years experience in research management, and clinical hospital management
● Research background in tumor and rare diseases, pathogenic mechanisms and vaccines
● Presided over a number of National Key Research Projects
● Ph.D. in Virology, Jilin University
Haihong Liu, M.D.
Technical Director of Clinical Laboratory
● Ex-Medical Laboratory Specialist of General Hospital of Beijing Military Region
● Genetic Metabolic Disease Laboratory Director of Bayi Children's Hospital
● Specialized in molecular biology and immunology diagnosis
● Evaluation expert of Beijing natural science foundation
● M.D. in preventive medicine, Academy of Military Medical Sciences
Wei Ye, Ph.D.
VP Scientific Affairs
● Head of Bioinformatics Platform, Bio-Med Big Data Center, Shanghai Institute of Biological Sciences, CAS, lead efforts of building NODE (National Omics Data Encylopedia)
● 10 years experience in multi-omics bioinformatics analysis
● Director of Bioinformatics, Shanghai Tissue Bank Co. Ltd.
● Project Assistant at Roche pRED China
● Ph.D. in Biology, Shanghai Jiaotong University
Atefeh Kazeroonian, Ph.D.
Computational Modelling Director
● Computational biologist, experienced in mechanistic modelling and omics data integration with a focus on the immune system
● Group leader in computational biology and T cell immunology, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich
● Ph.D., Computational Biology, Helmholtz Center in Munich in the Fabian Theis lab
● Visiting scholar, University of California, San Francisco
● Published multiple top tier publications (i.e. Nature Immunology, PNAS, Bioinformatics)
扫描二维码
关注 AliveX 微信公众号
Robin Chan, Ph.D.
VP of Strategic Partnerships
● 10+ years of experience in research and life science industry
● Founding director of Lipidomics Core Laboratory, Columbia University
● Assistant Professor of Pathology and Cell Biology, Lipid Metabolism and Neurodegenerative Diseases, Columbia University
● U.C. Berkeley Skydeck BioChina Fund partner
● PhD, Biochemistry, National University of Singapore, in the Lab of Markus R. Wenk; MBA, Columbia Business School
● Published 35+ top-tier publications (i.e. Nature, Nat Commun., Nat Neurosci., Cell Host Microbe), received research grants from National Institute of Health (NIH) and other non-profit research foundations
Chunjian Huang, Ph.D.
VP of Immunology
● 20+ years international experience in immunology-focused research institutes and biotechnology companies (e.g. cancer immunotherapy, autoimmunity, asthma and inflammation)
● Served as Director at Department of Oncology and Immunology, WuXi AppTec. Led R&D progress that enabled the development of new modalities and was involved in multiple successful IND applications
● Served as Principal Investigator at Innovent Biologics. Led team for first-in-class drug target discovery and successfully completed the POC of one FIC target within one year
● PostDoc, Cleveland Clinic (Department of Cancer Biology); Ph.D. in Immunology, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; B.Sc. in Biology, Fudan University
Wei Ye, Ph.D.
Co-founder/SVP of Technology Operations
● 10+ years experience in bioinformatics research institutes and pharmaceutical companies (focus on NGS, multi-omics data analysis, CADD)
● Served as Director of the Bioinformatics Platform, Shanghai Academy of Biological Sciences, Chinese Academy of Sciences. Led multiple national omics database setup and data analysis programs
● Served at the Roche R&D Center Bioinformatics and worked on several drug discovery projects
● Ph.D. in Biology (Bioinformatics), Shanghai Jiaotong University
● Published 20+ SCI papers, including 8 first-authored papers, with 500+ citations
End-to-end integrated platform for advanced biomarker discovery and target identification
End-to-end
integrated platform
for advanced
biomarker
discovery and
target identification
We generate & combine multi-omics data with systems biology, computational modelling and AI to advance human health through decoding of the immune system and identification of novel biomarkers & therapeutic targets.
We generate & combine multi-omics data with systems biology, computational modelling and AI to advance human health through decoding of the immune system and identification of novel biomarkers & therapeutic targets.
AliveX fundamental advantages
Our integrated multi-omics data generation and computational platforms enable us and our partners to empower novel discoveries, accelerate clinical trials and derive actionable insights.
AliveX fundamental advantages
Our integrated multi-omics data generation and computational platforms enable us and our partners to empower novel discoveries, accelerate clinical trials and derive actionable insights.
We transform the large population multi-omics data we and our partners generate to knowledge and insights, through our proprietary knowledge graph, data intelligence, AI & computational modelling pipelines; to ultimately reach a deep, mechanistic understanding of complex phenomena and uncover the "invisible" mechanisms governing them.
We transform the large population multi-omics data we and our partners generate to knowledge and insights, through our proprietary knowledge graph, data intelligence, AI & computational modelling pipelines; to ultimately reach a deep, mechanistic understanding of complex phenomena and uncover the "invisible" mechanisms governing them.
More than the sum
of its parts
contact@alivexbiotech.com
Zeunerstrasse 9, 8037 Zurich
